Exploring Horizons: today's achievements and tomorrow's ambitions
Industry supported symposium: AbbVie Ltd
Room 11, ACC Liverpool
Wednesday 20 April 2014
Faculty: Prof Paul Emery, Dr Karl Gaffney and Dr Raj Sengupta
Hosted by Prof Lord Winston
Aims and objectives
The meeting aims to look at:
- A decade of innovation in rheumatology and how advances in treatment protocols and the availability of anti-TNFs have led to achievable treatment goals that help optimise patient outcomes
The objectives of this meeting are to:
- • Discuss 10 years of innovation in rheumatology and healthcare innovation in the future
- Review revolving treatment goals for rheumatoid arthritis and clinical advances in spondyloarthritis
- Understand the implications of adherence and its role in achieving optimal patient outcomes
17.30 Reception – light refreshments
17.45 Exploring horizons... Back to the future of rheumatology
17.55 Exploring horizons...
- Advancing treatments goals in rheumatoid arthritis
- Clinical advances in spondyloarthritis (SpA)
- Patient support & adherence
18.55 Horizons special... How will healthcare transform in the next decade and beyond?
19.15 Meeting summary & close
Prescribing information will be available at the meeting. This promotional meeting is organised and funded by Abbvie Ltd.
Date of preparation: March 2014; AXHUR140124z(1)
